title: Timeline and potential impact of CMS's drug competitive acquisition program (CAP).
authors.affiliation: EB Rubinstein Associates, 371 Southridge Dr., Oak Park, CA 91377, USA. ebra@pacbell.net
authors.forename: Elan
authors.initials: E
authors.lastname: Rubinstein
mesh_terms: D003132:Commerce / Q000331:legislation & jurisprudence; D003164:Competitive Bidding; D004345:Drug Industry; D006278:Medicare / Q000331:legislation & jurisprudence*; D014481:United States